Friday , May 26 2017

Blog Layout

Ketones and Parkinson’s Disease

Parkinson’s disease (PD) is the second most common neurodegenerative disease. It is a progressive neurodegenerative disorder, characterized by tremors, slowness of movement, rigidity and problems with balance. These symptoms are believed to be due to the degeneration of the dopaminergic neurons in the substantia nigra. The mechanism of this neurodegeneration …

Read More »

Biochemical test shows promise for diagnosing Parkinson’s disease

Researchers have developed a biochemical test for diagnosing Parkinson’s disease (PD) using technology that detects misfolded α-synuclein (αSyn) oligomers in cerebrospinal fluid (CSF). Their protein misfolding cyclic amplification (PMCA) platform technology takes advantage of the ability of minute misfolded oligomers, in this case αSyn, to nucleate further aggregation, enabling a …

Read More »

Cures Bill Passes Senate

  Yesterday, the Senate voted 94 to 5 to pass the 21st Century Cures bill, which includes a long sought after national neurological disease surveillance system. Once the provision is funded, it will create a Parkinson’s disease registry at the Agency for Toxic Substances and Disease Registries (ATSDR) at the …

Read More »